PURE Bioscience, Inc. Announces 2024 Annual Meeting of Stockholders
Ticker: PURE · Form: DEF 14A · Filed: Jan 10, 2024 · CIK: 1006028
| Field | Detail |
|---|---|
| Company | Pure Bioscience, Inc. (PURE) |
| Form Type | DEF 14A |
| Filed Date | Jan 10, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 19 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: Proxy Statement, Annual Meeting, Stockholders, PURE Bioscience, SEC Filing
TL;DR
<b>PURE Bioscience, Inc. is holding its 2024 Annual Meeting of Stockholders on February 21, 2024, and is distributing proxy materials primarily online.</b>
AI Summary
PURE BIOSCIENCE, INC. (PURE) filed a Proxy Statement (DEF 14A) with the SEC on January 10, 2024. The 2024 Annual Meeting of Stockholders for PURE Bioscience, Inc. will be held on February 21, 2024, at 10:30 a.m. local time. The meeting will take place at SpringHill Suites Huntington Beach Orange County, located at 7872 Edinger Avenue, Huntington Beach, CA 92647. PURE Bioscience is utilizing the SEC's rules to furnish proxy materials primarily over the internet, aiming to reduce distribution costs and environmental impact. Stockholders received a Notice of Internet Availability of Proxy Materials on January 10, 2024, with instructions for accessing materials and voting. The proxy materials include the Proxy Statement and the Annual Report for the fiscal year ended July 31, 2023.
Why It Matters
For investors and stakeholders tracking PURE BIOSCIENCE, INC., this filing contains several important signals. The company is leveraging internet-based distribution for proxy materials to reduce costs and environmental impact, a common practice for public companies. The meeting serves as a key forum for stockholders to vote on corporate matters and receive updates on the company's operations and financial performance.
Risk Assessment
Risk Level: low — PURE BIOSCIENCE, INC. shows low risk based on this filing. The filing is a routine proxy statement for an annual meeting, containing no new financial or operational disclosures that would indicate significant risk.
Analyst Insight
Stockholders should review the proxy materials to understand the proposals being voted on and to participate in the annual meeting.
Key Numbers
- 2024-02-21 — Annual Meeting Date (Date of the 2024 Annual Meeting of Stockholders.)
- 10:30 a.m. — Meeting Time (Local time for the start of the 2024 Annual Meeting.)
- 2024-01-10 — Notice Mailing Date (Date the Notice of Internet Availability of Proxy Materials was sent to stockholders.)
- 2023-07-31 — Fiscal Year End (End date of the fiscal year covered by the Annual Report.)
Key Players & Entities
- PURE Bioscience, Inc. (company) — Registrant and filer of the proxy statement.
- February 21, 2024 (date) — Date of the 2024 Annual Meeting of Stockholders.
- January 10, 2024 (date) — Date the Notice of Internet Availability of Proxy Materials was mailed.
- July 31, 2023 (date) — End of the fiscal year for which the Annual Report is provided.
- SpringHill Suites Huntington Beach Orange County (company) — Location of the 2024 Annual Meeting of Stockholders.
- 7872 Edinger Avenue, Huntington Beach, CA 92647 (location) — Address of the meeting venue.
FAQ
When did PURE BIOSCIENCE, INC. file this DEF 14A?
PURE BIOSCIENCE, INC. filed this Proxy Statement (DEF 14A) with the SEC on January 10, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by PURE BIOSCIENCE, INC. (PURE).
Where can I read the original DEF 14A filing from PURE BIOSCIENCE, INC.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by PURE BIOSCIENCE, INC..
What are the key takeaways from PURE BIOSCIENCE, INC.'s DEF 14A?
PURE BIOSCIENCE, INC. filed this DEF 14A on January 10, 2024. Key takeaways: The 2024 Annual Meeting of Stockholders for PURE Bioscience, Inc. will be held on February 21, 2024, at 10:30 a.m. local time.. The meeting will take place at SpringHill Suites Huntington Beach Orange County, located at 7872 Edinger Avenue, Huntington Beach, CA 92647.. PURE Bioscience is utilizing the SEC's rules to furnish proxy materials primarily over the internet, aiming to reduce distribution costs and environmental impact..
Is PURE BIOSCIENCE, INC. a risky investment based on this filing?
Based on this DEF 14A, PURE BIOSCIENCE, INC. presents a relatively low-risk profile. The filing is a routine proxy statement for an annual meeting, containing no new financial or operational disclosures that would indicate significant risk.
What should investors do after reading PURE BIOSCIENCE, INC.'s DEF 14A?
Stockholders should review the proxy materials to understand the proposals being voted on and to participate in the annual meeting. The overall sentiment from this filing is neutral.
How does PURE BIOSCIENCE, INC. compare to its industry peers?
PURE Bioscience, Inc. operates in the chemical products sector, focusing on antimicrobial solutions. This filing is a standard proxy statement for its annual shareholder meeting.
Are there regulatory concerns for PURE BIOSCIENCE, INC.?
The filing is made under Section 14(a) of the Securities Exchange Act of 1934, which governs the solicitation of proxies from shareholders.
Industry Context
PURE Bioscience, Inc. operates in the chemical products sector, focusing on antimicrobial solutions. This filing is a standard proxy statement for its annual shareholder meeting.
Regulatory Implications
The filing is made under Section 14(a) of the Securities Exchange Act of 1934, which governs the solicitation of proxies from shareholders.
What Investors Should Do
- Review the proxy statement for details on proposals and voting procedures.
- Attend the annual meeting on February 21, 2024, or vote by proxy.
- Ensure contact information is up-to-date for future communications.
Key Dates
- 2024-01-10: Mailing of Notice of Internet Availability of Proxy Materials — Informs stockholders how to access proxy materials and vote.
- 2024-02-21: 2024 Annual Meeting of Stockholders — Key date for stockholders to vote on company matters and receive updates.
Year-Over-Year Comparison
This filing is a Definitive Proxy Statement (DEF 14A) for the 2024 Annual Meeting, indicating the company is providing final proxy materials to shareholders.
Filing Stats: 4,683 words · 19 min read · ~16 pages · Grade level 13.4 · Accepted 2024-01-10 16:30:10
Filing Documents
- formdef14a.htm (DEF 14A) — 594KB
- formdef14a_001.jpg (GRAPHIC) — 3KB
- formdef14a_002.jpg (GRAPHIC) — 96KB
- formdef14a_003.jpg (GRAPHIC) — 107KB
- 0001493152-24-001951.txt ( ) — 881KB
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 24 DIRECTOR COMPENSATION 28
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 29 SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE 30 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS 30 OTHER MATTERS 31 STOCKHOLDER PROPOSALS FOR 2023 ANNUAL MEETING 31 HOUSEHOLDING OF ANNUAL MEETING MATERIALS 31 ANNUAL REPORT 32 PURE BIOSCIENCE, INC. 771 Jamacha Rd. #512 El Cajon, CA 92019 PROXY TO BE HELD ON FEBRUARY 21, 2024 GENERAL INFORMATION The accompanying proxy is solicited by the Board of Directors (the “Board” or “Board of Directors”) of PURE Bioscience, Inc. (the “Company”) to be voted at the 2024 Annual Meeting of Stockholders (the “Meeting” or “Annual Meeting”) to be held on Wednesday, February 21, 2024 at SpringHill Suites Huntington Beach Orange County – 7872 Edinger Avenue, Huntington Beach, CA 92647 at 10:30 a.m., local time, and any adjournments or postponements thereof. This “Proxy Statement” and the accompanying proxy are being made available to our stockholders on or about January 10, 2024. References in this Proxy Statement to “the Company,” “we,” “PURE,” “our,” and “us” are to PURE Bioscience, Inc. In accordance with the rules of the Securities and Exchange Commission (the “SEC”), we are permitted to furnish proxy materials, including this Proxy Statement and our Annual Report for the fiscal year ended July 31, 2023 (the “Annual Report”) to stockholders by providing access to these documents through the internet instead of mailing printed copies. Most stockholders will not receive printed copies of the proxy materials unless requested. Instead, our Notice of Internet Availability of Proxy Materials provides instructions on how to access and review the proxy materials on the internet. The Notice of Internet Availability of Pro